Author:
Feld Jordan J.,Hoofnagle Jay H.
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Hoofnagle, J. H. et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. New Engl. J. Med. 315, 1575–1578 (1986).
2. Lau, D. T. et al. 10-year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology 28, 1121–1127 (1998).
3. Di Bisceglie, A. M. & Hoofnagle, J. H. Optimal therapy of hepatitis C. Hepatology 36, S121–S127 (2002).
4. McHutchison, J. G. & Poynard, T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin. Liver Dis. 19 (Suppl. 1), 57–65 (1999).
5. Glue, P. et al. Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin. Pharmacol. Ther. 68, 556–567 (2000).
Cited by
834 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献